IMUX SCHEDULE 13G/A: SEC filing
OrbiMed Advisors LLC, OrbiMed Genesis GP LLC, and OrbiMed Capital LLC
Filed with the SEC on · accession 0000947871-26-001032
IMUX filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. OrbiMed Advisors LLC, OrbiMed Genesis GP LLC, and OrbiMed Capital LLC filed an amended Schedule 13G reporting passive ownership of Immunic, Inc. common stock, with OrbiMed Advisors and Genesis each holding 314,409 shares (2.3%) and OrbiMed Capital holding 161,395 shares (1.2%), for an aggregate of… The stock moved -3.9% by the first close after the filing.
Summary of the filing
OrbiMed Advisors LLC, OrbiMed Genesis GP LLC, and OrbiMed Capital LLC filed an amended Schedule 13G reporting passive ownership of Immunic, Inc. common stock, with OrbiMed Advisors and Genesis each holding 314,409 shares (2.3%) and OrbiMed Capital holding 161,395 shares (1.2%), for an aggregate of 3.5%.
Key details
How IMUX stock reacted
Close before
$7.52
Nov 13, 2026
First close after
-3.86%
$7.23
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for IMUX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for IMUX?
Click hereFrequently asked questions
What did IMUX file with the SEC on Nov 16, 2026?
IMUX filed a SCHEDULE 13G/A (SEC filing). OrbiMed Advisors LLC, OrbiMed Genesis GP LLC, and OrbiMed Capital LLC filed an amended Schedule 13G reporting passive ownership of Immunic, Inc. common stock, with OrbiMed Advisors and Genesis each holding 314,409 shares (2.3%) and OrbiMed Capital holding 161,395 shares (1.2%), for an aggregate of 3.5%.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did IMUX stock react to this filing?
IMUX closed at $7.52 before the filing and $7.23 on Nov 16, 2026 (-3.86%).
Other IMUX SEC filings
- SCHEDULE 13G · SEC filingNov 13, 2026
- 8-K · SEC filingNov 13, 2026
- 10-Q · SEC filingNov 13, 2026
- 8-K · SEC filingNov 5, 2026
- SCHEDULE 13G/A · SEC filingNov 2, 2026
- 8-K · Board changeSep 11, 2026
- 8-K · SEC filingSep 9, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- SCHEDULE 13G · SEC filingAug 14, 2026
Get alerts when IMUX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days